2-Pyridyl P1′-Substituted Symmetry-Based Human Immunodeficiency Virus Protease Inhibitors (A-792611 and A-790742) with Potential for Convenient Dosing and Reduced Side Effects-Reference-Cited by-同舟云学术

2-Pyridyl P1′-Substituted Symmetry-Based Human Immunodeficiency Virus Protease Inhibitors (A-792611 and A-790742) with Potential for Convenient Dosing and Reduced Side Effects

Published:2009-03-26 Issue:8 Volume:52 Page:2571-2586
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

DeGoey David A.¹,Grampovnik David J.¹,Flentge Charles A.¹,Flosi William J.¹,Chen Hui-ju¹,Yeung Clinton M.¹,Randolph John T.¹,Klein Larry L.¹,Dekhtyar Tatyana¹,Colletti Lynn¹,Marsh Kennan C.¹,Stoll Vincent¹,Mamo Mulugeta¹,Morfitt David C.¹,Nguyen Bach¹,Schmidt James M.¹,Swanson Sue J.¹,Mo Hongmei¹,Kati Warren M.¹,Molla Akhteruzzaman¹,Kempf Dale J.¹

Affiliation:

1. Antiviral Research, Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm900044w

Reference35 articles.

1. Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir

2. Pharmacokinetic Enhancement of Protease Inhibitor Therapy

3. Peptidomimetic Inhibitors of HIV Protease